rdf:type |
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0017262,
umls-concept:C0073096,
umls-concept:C0081714,
umls-concept:C0185117,
umls-concept:C1366765,
umls-concept:C1366876,
umls-concept:C1412828,
umls-concept:C1704259,
umls-concept:C1705987,
umls-concept:C1833235,
umls-concept:C2911684
|
pubmed:issue |
3
|
pubmed:dateCreated |
2008-8-15
|
pubmed:abstractText |
The extracellular matrix metalloproteinase inducer (EMMPRIN) is significant in the regulation of matrix metalloproteinase (MMP) synthesis in atherosclerosis-related cells, and is possibly involved in the progression of atherosclerotic plaque. EMMPRIN expression is also up-regulated in PMA-induced THP-1 cells and is inhibited by resveratrol. However, it remains unclear how resveratrol inhibits EMMPRIN expression. We thus investigated the role of the MAPK signaling pathway in resveratrol inhibiting the up-regulation of EMMPRIN in PMA-induced THP-1 cells. We found that the ERK1/2 and p38 pathways, but not the JNK, are activated during the up-regulation of EMMPRIN expression. We also observed that while resveratrol suppresses the up-regulation of EMMPRIN, it also suppresses both the ERK1/2 and p38 pathways in a dose-dependent manner. Taken together, we established that it is through both the ERK1/2 and p38 MAPK pathways that resveratrol inhibits the expression of EMMPRIN in PMA-induced THP-1 cells.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD147,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/BSG protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Stilbenes,
http://linkedlifedata.com/resource/pubmed/chemical/Tetradecanoylphorbol Acetate,
http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...,
http://linkedlifedata.com/resource/pubmed/chemical/resveratrol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1090-2104
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
26
|
pubmed:volume |
374
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
517-21
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18647594-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:18647594-Antigens, CD147,
pubmed-meshheading:18647594-Antioxidants,
pubmed-meshheading:18647594-Cell Line,
pubmed-meshheading:18647594-Cell Survival,
pubmed-meshheading:18647594-Humans,
pubmed-meshheading:18647594-Mitogen-Activated Protein Kinase 1,
pubmed-meshheading:18647594-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:18647594-Protein Kinase Inhibitors,
pubmed-meshheading:18647594-Stilbenes,
pubmed-meshheading:18647594-Tetradecanoylphorbol Acetate,
pubmed-meshheading:18647594-p38 Mitogen-Activated Protein Kinases
|
pubmed:year |
2008
|
pubmed:articleTitle |
Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells.
|
pubmed:affiliation |
Department of Cardiology, XinHua Hospital, Shanghai Jiaotong University Medical School, 1665 Kongjiang Road, Shanghai 200092, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|